References
- United Nations Office on Drugs and Crime (UNODC), United Nations Office on Drugs and Crime, United Nations. World Drug Report 2017. Vienna: Division for Policy Analysis and Public Affairs; 2017.
- Kilibarda B, Simić D, Baroš S, Brandić I. National Report on Drug Situation in Serbia, 2014 [displayed 18 March 2020]. Available at http://www.emcdda.europa.eu/system/files/publications/ 805/National_Report_Serbia_2014_EN_483880.pdf
- European Monitoring Centre for Drugs and Drug Addiction. Serbia National Drug Report, 2017 [displayed 3 January 2018]. Available at http://www.emcdda.europa.eu/system/files/publications/4701/National%20drug%20report_Serbia.pdf_en
- Ministry of Health of the Republic of Serbia, Institute of Public Health of Serbia “Dr Milan Jovanović-Batut”, European School Project on Alcohol and other Drugs. European Survey on the use of Alcohol and Other Drugs among young people in Serbia, 2008 [displayed 18 March 2020]. Available at http://www.batut.org.rs/download/publikacije/ESPAD%20eng%202008.pdf
- Standridge JB, Adams SM, Zotos AP. Urine drug screening: a valuable office procedure. Am Fam Physician 2010;81:635–40. PMID: 20187600
- Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician 2008;11(Suppl 2):S155–80. PMID: 18443638
- Schulberg M, Gerostamoulos D. Urinary drug screening. Aust Prescr 2013;36:62–4. doi: 10.18773/austprescr.2013.051
- Tominaga M, Michiue T, Maeda H. Evaluation of the on-site immunoassay drug-screening device Triage-TOX in routine forensic autopsy. Leg Med (Tokyo) 2015;17:499–502. doi: 10.1016/j.legalmed.2015.10.007
- Moriya F. Urine levels of drugs for which Triage DOA screening was positive. Leg Med (Tokyo) 2009;11(Suppl 1):S434–6. doi: 10.1016/j.legalmed.2009.01.090
- Gomolka E. Immunoassay in toxicology diagnosis. In: Abuelzein E, editor. Trends in immunolabelled and related techniques. Rijeka: InTech; 2012. p. 67–82.
- Jaffee WB, Trucco E, Levy S, Weiss RD. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat 2007;33:33–42. doi: 10.1016/j.jsat.2006.11.008
- Zimbardi G. Workplace substance use, the risk of occupational injury, and testing [dissertation]. Pittsburgh: University of Pittsburgh; 2005.
- Riahi-Zanjani B. False positive and false negative results in urine drug screening tests: tampering methods and specimen integrity tests. PhOL 2014;1:102–8.
- Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc 2008;83:66–76. doi: 10.4065/83.1.66
- Schütz H, Erdmann F, Verhoff MA, Weiler G. Pitfalls of toxicological analysis. Leg Med (Tokyo) 2003;5(Suppl 1):S6– 19. doi: 10.1016/s1344-6223(02)00084-6
- Cone EJ, Lange R, Darwin WD. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test tesults. J Anal Toxicol 1998;22:460–73. doi: 10.1093/ jat/22.6.460
- Conel EJ, Caplan YH, Moser F, Robert T, Shelby MK, Black DL. Normalization of urinary drug concentrations with specific gravity and creatinine. J Anal Toxicol 2009;33:1–7. doi: 10.1093/jat/33.1.1
- Dasgupta A. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. Am J Clin Pathol 2007;128:491–503. doi: 10.1309/FQY06F8XKTQPM149
- USA Federal Register. Mandatory guidelines for federal workplace drug testing programs using urine specimens, Subpart H - Urine Specimen Collection Procedure. Federal Register Vol. 80, No. 94, 2015.
- Medicines and Medical Devices Agency of Serbia [displayed 18 March 2020]. Available at https://www.alims.gov.rs/eng/medical-devices/
- Rahdert E, Czechowicz D. Adolescent Drug abuse: Clinical Assessment and Therapeutic Interventions. NIDA Research Monograph 156. Rockville: National Institute on Drug Abuse Research; 1995.
- Washio Y, Fairfax-Columbo J, Ball E, Cassey H, Arria A, Bresani E. A review of guidelines on home drug testing websites for parents. J Addict Med 2014;8:258–63. doi: 10.1097/ ADM.0000000000000042
- Roškar R, Sollner Dolenc M. Determination of benzodiazepines in urine via benzophenone derivatives using liquid chromatography-tandem mass spectrometry. Arh Hig Rada Toksikol 2010;61:381–8. doi: 10.2478/10004-1254-61-2010-2058
- Schwarzhoff R, Cody J. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. J Anal Toxicol 1993;17:14–7. doi: 10.1093/jat/17.1.14
- Cody J, Schwarzhoff R. Impact on adulterants on RIA analysis of urine for drugs of abuse. J Anal Toxicol 1989;13:277–84. doi: 10.1093/jat/13.5.277
- Mikkelsen S, Ash O. Adulterants causing false negatives in illicit drug testing. Clin Chem 1988;34:2333–6. PMID: 3052928
- Warner A. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem 1989;35:648–51. PMID: 2539273